EVIDENCE TO ESTABLISH A NEW STANDARD OF CARE
Blood Culture Contamination: Target Zero
Clinically Proven Results
Steripath was exhaustively tested in a prospective, controlled, matched pair study performed by phlebotomists with results published in Clinical Infectious Diseases - with a sustained contamination rate of 0.2% and a 92% reduction in false positive results.
In many other published studies using Steripath, the average blood culture contamination rate was below or equal to 0.5% and also reduced contamination up to 92%.
University of Nebraska Medical Center
92% reduction in blood culture contamination estimated to save $1.8M per year
Clinical Infectious Diseases journal has published the results of a study from the University of Nebraska Medical Center led by Dr. Mark E. Rupp, Professor and Chief of the UNMC Division of Infectious Diseases and Medical Director of the Department of Infection Control and Epidemiology at Nebraska Medicine, UNMC’s hospital partner. The study validates the performance of the Steripath blood collection system to reduce blood culture contamination to 0.2% (P=0.001). This represented a 92% reduction compared to a pre-intervention rate of 2.6% and 88% reduction compared to the phlebotomist control group intervention rate of 1.8%. Post hoc analysis found contamination rates increased 12 fold to 2.8% without the use of Steripath. Researcher calculated the study institution would save $1.8M per year with Steripath
San Antonio Military Medical Center
92% reduction in blood culture contamination estimated to save $235,000 in less than five months
These study results show a 92% reduction in blood culture contamination, 7.7% using standard collection method vs. 0.6% utilizing Steripath, and a projected costs savings of $235,000 in five months.
Medical University of South Carolina
86% reduction in blood culture contamination driving expansion to an additional ED and ICU
Prospective study results showing an 86% reduction in blood culture contamination, 4.2% when using standard collection method vs. 0.6% utilizing Steripath. Results drove expansion of Steripath use to a second, separate adult ED, and the ICU.
San Antonio Military Medical Center
37% decrease in Vancomycin days of therapy
Retrospective study results showing a 37% decrease in Vancomycin days of therapy attributed to Steripath.
Rush University Medical Center
86% reduction in blood culture contamination
Prospective study results showing an 86% reduction in blood culture contamination, 4.3% when using standard aseptic technique vs. 0.6% utilizing Steripath. Steripath represents a simple and effective method for reducing blood culture contamination.
VA - North Texas Health Care System
69% reduction in blood culture contamination (blended rate) estimated to save $332,500 over five months
Poster presented as a Green Belt Project 2016, showed a post-Steripath adoption blended (combined Steripath and standard method results) blood culture contamination rate of 1.7% at 50% compliance compared to a pre-Steripath implementation of 5.3%, representing a 69% reduction. Steripath enabled a 45% reduction in blood culture collection steps and an estimated savings of $332,500 over a five month period.
Sustained Customer Results
In addition to clinical study environments, Steripath has repeatedly outperformed traditional blood culture collection methods in emergency departments across the nation.
"Implementing Steripath has dramatically decreased our contamination rates, resulting in savings through reduced length of stay and improved patient outcomes across all four campus emergency departments."
Mary B., MSN, RN, CEN, Fort Myers, FL
“[Steripath] has helped us to lower our blood culture contamination rates from above 3% on a monthly basis to below the national benchmark for every succeeding month after our initiation of the device. Magnolia provided great resources and training for the system which definitely aided in our success. The majority of the staff like the device and find it rather easy to use after the proper training. We are going to continue to use the device and ride along with Magnolia through this journey of success!”
Jessica P., MSN, RN, CEN, Cape Coral, FL
"The bottom line is that when a culture was drawn without the device (Steripath), we made no progress at all in our contamination rates. The average at the end of 16-weeks was 3%, actually up slightly from where we started. But when the device (Steripath) was used, the contamination rate was 0.7%, which is a 7% improvement in the contamination rate. That is really meaningful progress, and I thank everyone for making it happen!"
Jennifer Blakeney, MT(ASCP)SM, Lead Technologist Microbiology/Immunology, Beebe Healthcare
The evidence speaks for itself.
Let us share more.